Product Information
SYMBICORT 160-4.5 MCG INHALER is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $25.4574 per GM under NDC 00186037028. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 21, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
160; 4.5 ug/1; ug/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00186037028
Classification
Brand
Dosage Form
AEROSOL
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
BUDESONIDE; FORMOTEROL FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA021929FDA Approved
7/21/2006
TE Code
AB
On Market Since
5/29/2007
Pharmacological Classes
Price Statistics
The NADAC for SYMBICORT 160-4.5 MCG INHALER has been published 671 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $25.4574 per GM |
|---|---|
| All-time high | $42.1256 (Jan 3, 2024) |
| All-time low | $25.2745 (Jan 10, 2024) |
| 52-week high | $25.4574 |
| 52-week low | $25.3442 |
| Median price | $33.4790 |
| Average price | $33.5087 |
| Largest weekly change | -40.0% (Jan 10, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AstraZeneca Pharmaceuticals LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide and Formoterol Fumarate Dihydrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SYMBICORT 160-4.5 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for SYMBICORT 160-4.5 MCG INHALER, manufactured by AstraZeneca Pharmaceuticals LP, is $25.4574 per GM (NDC 00186037028), effective Sep 30, 2026.
How has the price of SYMBICORT 160-4.5 MCG INHALER changed over time?
Over the history we have for it, the NADAC for SYMBICORT 160-4.5 MCG INHALER has held within roughly two percent of its current level. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SYMBICORT 160-4.5 MCG INHALER?
Since Nov 28, 2013, the NADAC for SYMBICORT 160-4.5 MCG INHALER has ranged from a low of $25.2745 (Jan 10, 2024) to a high of $42.1256 (Jan 3, 2024), with a median of $33.4790 per GM.
Are there cheaper alternatives to SYMBICORT 160-4.5 MCG INHALER?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE-FORMOTEROL 160-4.5, is $17.2645 per GM — about 32% below SYMBICORT 160-4.5 MCG INHALER.
Who manufactures SYMBICORT 160-4.5 MCG INHALER?
SYMBICORT 160-4.5 MCG INHALER (NDC 00186037028) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.